Pelizaeus-Merzbacher Syndrome: A Rare Demyelinating Disorder in Context
Reference links shared on this blog may become inaccessible soon, as the new 2025 U.S. administration is reportedly considering halting the public release of federal health data. According to a recent Reuters article, the administration may suspend public reporting of health data from federal agencies like the FDA, CDC, and DHS. Pelizaeus-Merzbacher Syndrome (PMS) is a rare, inherited demyelinating disorder , primarily affecting infants and children. While PMS is most commonly discussed in the realm of pediatric leukodystrophies, understanding it in the broader context of demyelinating disorders—such as multiple sclerosis (MS) , transverse myelitis , and even white matter conditions affecting adults—reveals its broader neurological implications. Exploring this syndrome through the lens of a prototypic adult's perspective sheds light on how white matter diseases influence the nervous system at all ages and across a spectrum of conditions. What is Demyelination? Demyelination refers...